AboutCOVID-19Careers in pharmacologyNewsEventsEducation & engagementPartner with UsPublishingMembership & awardsMy BPS & resources

Increased risk of gastrointestinal adverse effects under SSRI/NSAID combination may be due to pharmacokinetic interactions

Article date: January 2005

By: Daniele Fabio Zullino, Yasser Khazaal, in Volume 59, Issue 1, pages 118-119

DOI: 10.1111/j.1365-2125.2005.2212_1.x

View this article

Publishing

Contact us

About this website

Become a member

BPS Assessment Ltd

BPS on LinkedIn BPS on Bluesky BPS on Facebook BPS on Instagram BPS on Reddit BPS on ThreadsBPS on YouTube

British Pharmacological Society is a registered UK charity - Charity No. 1030623. It is also a company limited by guarantee registered in England and Wales - Company Number 2877400.
Its registered office is The Schild Plot, 16 Angel Gate, City Road, London, EC1V 2PT, United Kingdom

© 2025 British Pharmacological Society. All rights reserved.